Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.66	120.85	116.58
Graham Fair Price	-22.63	2.89	3.73
PEG	69.24	-0.47	0.28
Price/Book	-11.86	1.95	2.21
Price/Cash Flow	-74.57	158.57	623.52
Prices/Earnings	74.30	72.35	-41.51
Price/Sales	-19.68	7.81	9.73
Price/FCF	-74.57	158.57	623.52
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.64	0.19	0.24
Operating Margin	37.04	0.04	-0.03
ROA	-49.01	< 0.005	< 0.005
ROE	-0.01	< 0.005	-49.43
ROIC	< 0.005	< 0.005	-40.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	< 0.005	913.15
Dividends QOQ	-0.62	0.82	31.53
EBIT QOQ	-1.23	2.48	102.46
EPS QOQ	-1.51	1.55	2.99
FCF QOQ	-0.92	2.41	162.50
Revenue QOQ	-0.29	0.08	-71.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	131.83	115.62	-12.30
Days Sales Outstanding (DSO)	154.62	136.28	-11.87
Inventory Turnover	0.68	0.78	14.02
Debt/Capitalization	0.24	0.25	4.98
Quick Ratio	1.37	1.30	-5.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.82	7.42	8.80
Cash	3.29	3.47	5.29
Capex	-0.28	-0.10	63.22
Free Cash Flow	0.02	0.09	277.06
Revenue	1.55	1.85	19.39
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.91	1.83	-3.82
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.94	-9.19	7.54
Naive Interpretation	Member

06 - Financial Health · Weak

Rating